COSMOS Pharmaceutical

TYO-3349
Tokyo Stock Exchange
Healthcare Medical - Pharmaceuticals
Global Rank
#5284
Country Rank
#372
Market Cap
3.16 B
Price
38.56
Change (%)
3.20%
Volume
437,900

COSMOS Pharmaceutical's latest marketcap:

3.16 B

As of 04/30/2026, COSMOS Pharmaceutical's market capitalization has reached $3.16 B. According to our data, COSMOS Pharmaceutical is the 5284th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 3.16 B
Revenue (ttm) 6.82 B
Net Income (ttm) 200.25 M
Shares Out 79.26 M
EPS (ttm) 2.53
Forward PE 15.01
Ex-Dividend Date 05/28/2026
Earnings Date 04/13/2026
Market Cap Chart
Data Updated: 04/30/2026

COSMOS Pharmaceutical's yearly market capitalization.

COSMOS Pharmaceutical has seen its market value grow from ¥325.7 B to ¥461.99 B since 2014, representing a total increase of 41.84% and an annual compound growth rate (CAGR) of 3.11%.
Date Market Cap(¥) Market Cap(USD) Change (%) Global Rank
06/01/2026 ¥461.99 B $2.95 B -26.61% n/a
12/30/2025 ¥629.54 B $4.05 B 18.61% 3129
12/30/2024 ¥530.79 B $3.38 B -17.69% 3980
12/29/2023 ¥644.87 B $4.57 B 22.08% 3068
12/30/2022 ¥528.25 B $4.03 B -21.21% 3221
12/30/2021 ¥670.41 B $5.83 B 1.5% 2832
12/30/2020 ¥660.51 B $6.39 B 47.87% 2347
12/30/2019 ¥446.68 B $4.11 B 22.94% 2747
12/28/2018 ¥363.32 B $3.31 B -22.01% 2812
12/29/2017 ¥465.88 B $4.13 B 9.19% 2715

Company Profile

About COSMOS Pharmaceutical Corporation

COSMOS Pharmaceutical Corporation is a leading retail company specializing in the sale of pharmaceuticals, cosmetics, daily necessities, and food products in Japan. Founded in 1983 and headquartered in Fukuoka City, the company serves customers both in-store and through its online platforms.

Key Business Activities

  • Retail sale of pharmaceuticals and healthcare products
  • Distribution of cosmetics and personal care items
  • Supply of daily necessities and household goods
  • Food retailing
  • E-commerce operations via online stores

With decades of experience in the industry, COSMOS Pharmaceutical Corporation continues to expand its market presence while maintaining a strong commitment to quality and customer satisfaction.

Frequently Asked Questions

  • What is COSMOS Pharmaceutical's (TYO-3349) current market cap?
    As of 04/30/2026, COSMOS Pharmaceutical (including the parent company, if applicable) has an estimated market capitalization of $3.16 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • COSMOS Pharmaceutical global market capitalization ranking is approximately 5284 as of 04/30/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Research Tools

Copyright © 2026. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.